Patient Guide: Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 20 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06121375
Status: 🟢 Enrolling Now
Condition: Biliary Atresia
Phase: PHASE2, PHASE3

Where You Can Participate

This study is available at 20 locations across the country.

Top locations include:
  • • South Brisbane, Queensland
  • • North Adelaide, South Australia
  • • Parkville, Victoria
  • • And 17 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy - Join Clinical Trial NCTNCT06121375

How to Join This Clinical Trial - NCTNCT06121375

Learn how to participate in this PHASE2, PHASE3 trial studying an investigational therapy for Biliary Atresia. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Biliary Atresia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Biliary Atresia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2, PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06121375 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 20 locations. Find a study site near you:

Clinical Research Site

South Brisbane, Queensland 4101 - Australia

Status: RECRUITING

Clinical Research Site

North Adelaide, South Australia 5006 - Australia

Status: RECRUITING

Clinical Research Site

Parkville, Victoria 3104 - Australia

Status: RECRUITING

Clinical Research Site

Calgary, Alberta T3B 6A8 - Canada

Status: RECRUITING

Clinical Research Site

Edmonton, Alberta - Canada

Status: RECRUITING

Clinical Research Site

Hangzhou, Zhejiang 310006 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Hong Kong, - Hong Kong

Status: RECRUITING

Clinical Research Site

Jerusalem, - Israel

Status: RECRUITING

Clinical Research Site

Jerusalem, - Israel

Status: RECRUITING

Clinical Research Site

Kota Bharu, Kelantan 15586 - Malaysia

Status: RECRUITING

And 10 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2, PHASE3 clinical trial for Biliary Atresia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships